Difluorinated thromboxane A2 reveals crosstalk between platelet activatory and inhibitory pathways by targeting both the TP and IP receptors. (2024)

First Author: Allen MF

Attributed to: Synthesis and Biology of Prostanoids funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bph.16435

PubMed Identifier: 38840293

Publication URI: http://europepmc.org/abstract/MED/38840293

Type: Journal Article/Review

Parent Publication: British journal of pharmacology

ISSN: 0007-1188